38,022,140 Ordinary Shares of Island Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 13-APR-2023. These Ordinary Shares will be under lockup for 736 days starting from 7-APR-2021 to 13-APR-2023.

Details:
An aggregate of 38,022,140 fully paid ordinary shares classified by ASX as restricted securities will be held in escrow until April 13, 2023, being 24 months from the date of commencement of Official Quotation.

An aggregate of 2,428 fully paid ordinary shares classified by ASX as restricted securities will be held in escrow until February 10, 2022, being 12 months from the date of issue.

An aggregate of 565 fully paid ordinary shares classified by ASX as restricted securities will be held in escrow until February 11, 2022, being 12 months from the date of issue.

An aggregate of 169 fully paid ordinary shares classified by ASX as restricted securities will be held in escrow until February 17, 2022, being 12 months from the date of issue.

An aggregate of 177,778 options exercisable at AUD 0.3125 on or before April 30, 2024, classified by ASX as restricted securities will be held in escrow until April 13, 2023, being 24 months from the date of commencement of Official Quotation.

An aggregate of 177,778 options exercisable at AUD 0.3750 on or before April 30, 2024, classified by ASX as restricted securities will be held in escrow until April 13, 2023, being 24 months from the date of commencement of Official Quotation.

An aggregate of 177,777 options exercisable at AUD 0.4375 on or before April 30, 2024, classified by ASX as restricted securities will be held in escrow until April 13, 2023, being 24 months from the date of commencement of Official Quotation.

An aggregate of 67,866 options exercisable at AUD 0.3730 on or before April 4, 2023, classified by ASX as restricted securities will be held in escrow until April 13, 2023, being 24 months from the date of commencement of Official Quotation.

An aggregate of 3,925,000 options exercisable at AUD 0.3625 on or before April 30, 2024, classified by ASX as restricted securities will be held in escrow until April 13, 2023, being 24 months from the date of commencement of Official Quotation.

An aggregate of 58,389 options exercisable at AUD 0.2130 on or before April 7, 2024, classified by ASX as restricted securities will be held in escrow until 7 April 2022, being 12 months from the date of issue.

An aggregate of 3,669,744 options exercisable at AUD 0.3125 on or before April 13, 2024, classified by ASX as restricted securities will be held in escrow until April 13, 2023, being 24 months from the date of commencement of Official Quotation.

An aggregate of 6,710,041 shares will be held in escrow until 6 months from date of quotation.